CAS: 5625-41-2 - 3,6-Bis(hydroxymethyl)-2,5-piperazinedione
Formula:C6H10N2O4
InChI:InChI=1S/C6H10N2O4/c9-1-3-5(11)8-4(2-10)6(12)7-3/h3-4,9-10H,1-2H2,(H,7,12)(H,8,11)
InChI key:InChIKey=SUWGHSHLNOADHI-UHFFFAOYSA-N
SMILES:O=C1NC(C(=O)NC1CO)CO
- Synonyms:
- NSC 508753
- Serine, bimol. cyclic peptide
- 3,6-Bis(hydroxymethyl)-2,5-piperazinedione
- 2,5-Piperazinedione, 3,6-bis(hydroxymethyl)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Cycloserine Impurity 6 (Mixture of Diastereomers) REF: 4Z-C-11316CAS: 5625-41-2 | - - - | To inquire | Fri 24 Jan 25 | |
3,6-Bis(hydroxymethyl)-2,5-piperazinedione REF: TR-B419065CAS: 5625-41-2 | - - - | 347.00 €~2,290.00 € | Tue 04 Feb 25 | |
3,6-Bis(hydroxymethyl)piperazine-2,5-dione REF: 3D-FAA62541CAS: 5625-41-2 | Min. 95% | To inquire | Thu 06 Mar 25 | |
3,6-Bis(hydroxymethyl)piperazine-2,5-dione REF: 10-F656815CAS: 5625-41-2 | 98% | - - - | Discontinued product |
Cycloserine Impurity 6 (Mixture of Diastereomers)
CAS:5625-41-2
Formula:
C6H10N2O4
Molecular weight:
174.16
Ref: 4Z-C-11316
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 24 Jan 2025
3,6-Bis(hydroxymethyl)-2,5-piperazinedione
Controlled ProductCAS:5625-41-2
Applications 3,6-Bis(hydroxymethyl)-2,5-piperazinedione is an intermediate in the synthesis of impurities of Cycloserine (C988800), an antibacterial …
Formula:
C6H10N2O4
Color and Shape:
Neat
Molecular weight:
174.15
Ref: TR-B419065
50mg | 347.00 € | ||
500mg | 2,290.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025
3,6-Bis(hydroxymethyl)piperazine-2,5-dione
CAS:5625-41-2
Versatile small molecule scaffold
Formula:
C6H10N2O4
Purity:
Min. 95%
Molecular weight:
174.15 g/mol
Ref: 3D-FAA62541
1g | 1,871.00 € | ||
100mg | 729.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
Ref: 10-F656815
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |